搜索临床试验以:PRV111(顺铂穿粘膜系统)
总计455个结果
-
Privo TechnologiesNational Cancer Institute (NCI)完全的
-
Icahn School of Medicine at Mount Sinai撤销
-
First People's Hospital of HangzhouCollege of Pharmaceutical Sciences at Zhejiang University; The Innovation Institute for Artificial...尚未招聘
-
Asan Medical CenterBoryung Pharmaceutical Co., Ltd终止
-
Matthew GalskyNovartis终止
-
AbbVie招聘中晚期实体瘤美国, 大韩民国, 以色列, 日本, 澳大利亚, 西班牙
-
Janssen Research & Development, LLC主动,不招人
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); University of Pittsburgh; AIM ImmunoTech Inc.暂停
-
The First Affiliated Hospital with Nanjing Medical...尚未招聘评价安罗替尼联合同步放化疗治疗局部晚期宫颈癌的疗效和安全性
-
Robert FerrisBristol-Myers Squibb完全的
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)完全的
-
Pomeranian Medical University SzczecinMaria Sklodowska-Curie National Research Institute of Oncology完全的
-
Fondazione Michelangelo完全的
-
Cancer Institute and Hospital, Chinese Academy...Peking University Cancer Hospital & Institute招聘中
-
AstraZeneca主动,不招人非小细胞肺癌波兰, 印度, 泰国, 越南, 火鸡, 大韩民国, 巴西, 捷克语, 匈牙利, 日本, 墨西哥, 秘鲁, 菲律宾, 俄罗斯联邦
-
AstraZeneca招聘中
-
Affiliated Cancer Hospital & Institute of Guangzhou...尚未招聘肺癌 | 放疗 | 广泛期小细胞肺癌